Stay updated with breaking news from Berlin Cures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BERLIN, GERMANY / ACCESSWIRE / April 23, 2024 / Berlin Cures, a pioneering clinical-stage biotechnology company, today announced the successful completion of patient screening for its pan-European Phase II trial of BC 007 (Rovunaptabin), a novel therapeutic candidate for the treatment of Long COVID. The study has no...
Screening Completed: Berlin Cures Achieves Key Milestone in BC 007 ...
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding...
03.04.2024 - BERLIN, GERMANY / ACCESSWIRE / April 3, 2024 / Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board. The aim of the board is to advise on ...
I have long Covid. In March 2020, I was swimming 40 lengths before working a 10-hour day. Now, I can barely walk 400 steps in one go.